Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001144204-10-011889

Options or other derivatives

  • President and CMO acquired 500,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Hoffman Daniel A President and CMO 2010-03-03 Grant or award · Stock Option (Right to Buy) +500,000 500,000 D
Loading xslF345X03/v176516_ex.xml…